Network Spotlight: University Medical Center Schleswig-Holstein (UKSH)
We are honored to recognize UKSH for their partnership with TriNetX. In the ever-evolving landscape of healthcare, collaboration isn’t just beneficial; it’s essential. TriNetX is proud to partner with our network to advance healthcare through rigorous research,...
Real-World Data To Improve Clinical Trial Design
Many clinical trials struggle to enroll patients, hindering meaningful results and delaying the delivery of therapies to patients. Real-world data (RWD) addresses this by overcoming barriers such as overly strict enrollment criteria and disconnects between research...
The Growing Influence of Real-World Data and Evidence
Some of the most prominent and visible roles of real-world data (RWD) and real-world evidence (RWE) are regulatory and clinical decision-making and disease research. However, RWD and RWE have been growing in influence in many other areas of healthcare and in regions...
Detecting Pancreatic Cancer with TriNetX AI: The PDAC Risk Model Breakthrough
Powered By TriNetX MIT and BIDMC’s study published by The Lancet introduces PRISM, a model for early pancreatic cancer risk, using a database of over 156 million de-identified US patients from TriNetX, LLC. PRISM accurately forecasts pancreatic cancer risk 18...
Growing Need for Diversity in Clinical Trials
Earlier this year, the FDA rejected an application for a new cancer drug because it was based on a trial conducted in China, and the agency ruled it did not represent the U.S. population.[1] In 2021, the FDA’s Oncologic Drugs Advisory Committee noted in their review...
TriNetX Joins CERTAINTY Project to Enhance Cancer Immunotherapy
Cambridge, MA, January 31, 2024 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, is proud to announce its participation in the CERTAINTY project. CERTAINTY, short for CEllulaR...
TriNetX Recognized on the 2023 Fortune Impact 20 List for Pioneering Advancements in Clinical Trial Diversity
Cambridge, MA, December 18, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has been named to the 2023 Fortune Impact 20 list. The selection tabs TriNetX as one of the top 20...
TriNetX Showcases Pioneering Role in Advancing Healthcare through Innovative Medical Technologies
Cambridge, MA, December 7, 2023 — TriNetX, LLC (“TriNetX”) is the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, proudly participating in an important video series, “Connecting the Dots.” The...